MARKET

NVRO

NVRO

Nevro
NYSE

Real-time Quotes | Nasdaq Last Sale

169.30
-6.63
-3.77%
Closed 17:19 01/27 EST
OPEN
173.08
PREV CLOSE
175.93
HIGH
174.85
LOW
168.36
VOLUME
497.11K
TURNOVER
--
52 WEEK HIGH
188.14
52 WEEK LOW
65.05
MARKET CAP
5.83B
P/E (TTM)
-62.2335
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire via COMTEX/ -- REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical...
PR Newswire - PRF · 23h ago
Neurostimulation Devices Market 2021 Trends, Covid-19 Impact Analysis, Supply Demand Scenario and Growth Prospects Survey till 2026 investigated in the latest research
Jan 27, 2021 (Market Insight Reports) -- Report Ocean has added research publication document on Neurostimulation Devices Market breaking major business...
Market Insight Reports · 1d ago
MRI Safe Neurostimulation Systems Market – Global Coronavirus Impact (Covid-19) Business Impact Competition Outlook By 2027
Jan 27, 2021 (AmericaNewsHour) -- The MRI Safe Neurostimulation Systems market can be segmented on the basis of product type, application, end user and...
AmericaNewsHour · 1d ago
Pain Management Devices Market Size, Share 2021: Industry Trends and Investigation Growth Rate, consumption by Regional data, Product & Application Segmentation, Key Companies and Analysis By
● Global “ Pain Management Devices Market” By Type (Electrical Stimulation Devices,Radiofrequency Ablation Devices,Neurostimulation Devices,Others), By...
The Express Wire · 1d ago
Adult Neurosurgery Devices Market Analysis, Trends, Growth, Size, Share and Forecast 2020 to 2026
Jan 21, 2021 (Heraldkeepers) -- The global Adult Neurosurgery Devices market report provides geographic analysis covering regions, such as North America,...
Heraldkeepers · 6d ago
Nevro Corp.'s (NYSE:NVRO) Path To Profitability
Nevro Corp. ( NYSE:NVRO ) is possibly approaching a major achievement in its business, so we would like to shine some...
Simply Wall St. · 01/21 08:39
Gastric Electrical Stimulation (Ges) Market Forecast Value and Market Share by Types, Application, Region, and Covid-19 Influence 2021 to 2025
Jan 21, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Gastric Electrical Stimulation...
The Express Wire · 01/21 08:32
Internal Neuromodulation Market Outlook 2026: Top Companies, Trends and Growth Factors Details for Business Development
Jan 21, 2021 (The Expresswire) -- Global “Internal Neuromodulation Market” forecast 2026, research report analyzed the existing state of the market by...
The Express Wire · 01/21 06:49
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NVRO. Analyze the recent business situations of Nevro through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NVRO stock price target is 194.42 with a high estimate of 215.00 and a low estimate of 150.00.
EPS
Institutional Holdings
Institutions: 312
Institutional Holdings: 41.85M
% Owned: 121.56%
Shares Outstanding: 34.43M
TypeInstitutionsShares
Increased
79
1.28M
New
59
-630.69K
Decreased
76
2.41M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-3.07%
Healthcare Equipment & Supplies
-2.98%
Key Executives
Chairman/President/Chief Executive Officer/Director
D.Keith Grossman
Chief Financial Officer
Roderick MacLeod
Chief Human Resource Officer
Lori Ciano
Chief Compliance Officer/General Counsel/Secretary
Kashif Rashid
Vice President - Operations
Patrick Schmitz
Vice President/Director of Sales
Michael Carter
Vice President/Director of Investor Relations/IR Contact Officer
Juliet Cunningham
Vice President/Director of Investor Relations
Julie Dewey
Vice President
Donald Middlebrook
Vice President - Research & Development
Christopher Christoforou
Other
David Caraway
Other
Niamh Pellegrini
Lead Director/Independent Director
Michael DeMane
Director
Susan Siegel
Independent Director
Frank Fischer
Independent Director
Shawn McCormick
Independent Director
Kevin O'Boyle
Independent Director
Karen Prange
Independent Director
Brad Vale
Independent Director
Elizabeth Weatherman
  • Dividends
  • Splits
  • Insider Activity
No Data
About NVRO
Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.

Webull offers kinds of Nevro Corp stock information, including NYSE:NVRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVRO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NVRO stock methods without spending real money on the virtual paper trading platform.